Cargando…
Nitroglycerin: a comprehensive review in cancer therapy
Nitroglycerin (NTG) is a prodrug that has long been used in clinical practice for the treatment of angina pectoris. The biotransformation of NTG and subsequent release of nitric oxide (NO) is responsible for its vasodilatating property. Because of the remarkable ambivalence of NO in cancer disease,...
Autores principales: | Meunier, Mélina, Yammine, Aline, Bettaieb, Ali, Plenchette, Stéphanie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10182021/ https://www.ncbi.nlm.nih.gov/pubmed/37173331 http://dx.doi.org/10.1038/s41419-023-05838-5 |
Ejemplares similares
-
S-nitrosylation in TNF superfamily signaling pathway: Implication in cancer()
por: Plenchette, Stéphanie, et al.
Publicado: (2015) -
Precision medicine in breast cancer: reality or utopia?
por: Bettaieb, Ali, et al.
Publicado: (2017) -
Senescence and Cancer: Role of Nitric Oxide (NO) in SASP
por: Mabrouk, Nesrine, et al.
Publicado: (2020) -
Nitric Oxide-Releasing Drug Glyceryl Trinitrate Targets JAK2/STAT3 Signaling, Migration and Invasion of Triple-Negative Breast Cancer Cells
por: Bouaouiche, Sarra, et al.
Publicado: (2021) -
Nitroglycerine
Publicado: (1895)